DR. AMIR TABATABAI (M.D.) – Hematology & Oncology Physician, NPI 1871592154

DR. AMIR TABATABAI (M.D.) is a healthcare provider. based in York, Pennsylvania. specializing in HEMATOLOGY/ONCOLOGY. They hold the professional credentials M.D.. They hold a License No. C144611 (CA). The NPI Number for DR. AMIR TABATABAI (M.D.) is 1871592154

Main info

Male
32 Years Of Experience
Accepts Medicare Assignment
Name
DR. AMIR TABATABAI (M.D.)
NPI
1871592154
Phone
(717) 741-9229
Address
25 MONUMENT RD
Enumeration Date
19 July 2005
Last Update Date
12 April 2026

Doctor Profile

Medical School Name
OTHER
Secondary Phone
8314277110
Graduation Year
1994 (32 years ago)
PAC ID
7416910641
Group Practice PAC ID
7810800661
Professional Enrollment ID
I20230106000664
Address ID
CA950651526SA1779XWAYX301
Telehealth
Yes
Data current as of
19 May 2026

Profile Insights

NPPES metrics only — not quality of care.

Methodology
Experience73
Completeness85
Years active:20State licenses:2Digital endpointsOther names

1,536 HEMATOLOGY/ONCOLOGY in CA

Provider Addresses for DR. AMIR TABATABAI (M.D.)

  • Apple Hill Medical Center, 25, Monument Road, Chanticleer, York, York County, Pennsylvania, 17403, United States

    SUITE 294

    YORK, PA 174035060

    Phone: (717) 741-9229

    Fax: (717) 741-9605

    Type: Mailing

  • 15400 NATIONAL AVE STE 201

    LOS GATOS, CA 950322433

    Phone: (408) 358-8415

    Type: Mailing

  • 3400 DATA DR

    RANCHO CORDOVA, CA 956707956

    Phone:

    Type: Mailing

  • 1779 DOMINICAN WAY STE B

    SANTA CRUZ, CA 950651526

    Phone: (831) 427-7110

    Fax: (861) 462-1024

    Type: Location

NPPES updates history

No NPPES updates recorded for this provider.

Prescription Activity

Loading prescription activity...

Open Payments (CMS)

CMS reports 4 Open Payments records for all available years, with a total value of $51.

Total Amount is formed as General ($51) + Research ($0) + Ownership ($0) = $51.

Last reported payment date: 2024-01-18 • Largest payer in this snapshot: Celgene Corporation ($15).

Total Amount

$51

General + Research + Ownership

Payments

4

Total payment records

General Amount

$51

General payments

Research Amount

$0

Research funding

Ownership Amount

$0

Ownership interests

Ownership Count

0

Ownership records

Last Payment Date

2024-01-18

Latest reported date

Top Companies

Largest payers in this snapshot

View all Open Payments →|Open Payments Risk Radar →

Medicare Enrollment & Revalidation

Source: CMS public data · Not endorsed by CMS ·

Educational use only—not medical, billing, or legal advice.

PECOS enrollment status

Participating (accepts Medicare assignment)

Enrollment effective: 2023-01-06

PECOS data refreshed: 2026-06-15

Medicare revalidation (CMS due date list)

Due date not assigned yet

CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.

Enrollment records

1

Earliest due date

Not assigned (TBD)

CMS data updated

2026-06-01

Revalidation progress

  1. Medicare enrolled
  2. On CMS revalidation list
  3. Due date assigned
  4. Revalidate in PECOS

CMS enrollment records

Enrollment IDTypeSpecialtyStateDue date
I20230106000664IHematology/OncologyCATBD

What to do next

  • No action required while the due date shows TBD.
  • Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
  • Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.

Verify on CMS Revalidation Lookup Tool

Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS

Medicare Utilization (FFS)

Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·

Educational use only—not medical, billing, or legal advice.

Top Medicare procedures (2023) · refreshed 2026-05-27

HCPCSDescriptionServicesBeneficiariesMedicare allowed
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)19,17543$0
J9271Injection, pembrolizumab, 1 mg11,60128$0
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj8,10022$0
J9299Injection, nivolumab, 1 mg7,48013$0
J9263Injection, oxaliplatin, 0.5 mg6,82112$0
View full utilization report →

Insurance plans in this area (ZIP 17403)

Loading plans...

Provider's Procedures

DR. AMIR TABATABAI (M.D.) performs procedures in HEMATOLOGY/ONCOLOGY. See the list of HCPCS codes below.
SpecialtyPractice State
HCPCS Code
Description
Service Count
Beneficiary Count
HEMATOLOGY/ONCOLOGYPA96367Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour398115

Group practice members

Group practice members are other physicians who share the same Group Practice PAC ID with this doctor. When doctors form a group practice and register in PECOS as a single entity, they receive a shared identification number. This table lists all providers in the same group practice.
PAC ID: 7810800661View full group profile

Reviews

All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.

No reviews yet. Be the first to share your experience — your opinion helps families compare providers.

Frequently asked questions

What is the registry number for DR. AMIR TABATABAI (M.D.)?
The registry entry for DR. AMIR TABATABAI (M.D.) shows NPI 1871592154.
Is DR. AMIR TABATABAI (M.D.)'s NPI status active today?
Active status means DR. AMIR TABATABAI (M.D.)'s NPI record is not deactivated in the public file.
What type of care does DR. AMIR TABATABAI (M.D.) provide?
DR. AMIR TABATABAI (M.D.)'s profile centers on Hematology & Oncology Physician. Clinical services aligned with this taxonomy classification.
What geographic area is tied to DR. AMIR TABATABAI (M.D.)?
DR. AMIR TABATABAI (M.D.) is associated with York, Pennsylvania in the same public data insurers reference.
Who maintains DR. AMIR TABATABAI (M.D.)'s record?
Providers certify NPPES data; CMS hosts the public file you are viewing.